The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,984.00
Bid: 11,978.00
Ask: 11,984.00
Change: -40.00 (-0.33%)
Spread: 6.00 (0.05%)
Open: 11,950.00
High: 11,986.00
Low: 11,944.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-U.S. directs millions of COVID-19 shots to Latin America, Africa, Asia

Mon, 21st Jun 2021 17:33

(Adds comments from White House spokesperson)

By Jeff Mason

June 21 (Reuters) - The White House laid out a plan on
Monday to share 55 million U.S. COVID-19 vaccine doses globally,
with roughly 75% of the doses allocated to Latin America and the
Caribbean, Asia and Africa through the COVAX international
vaccine-sharing program.

The plan fulfills President Joe Biden's commitment to share
80 million U.S.-made vaccines with countries around the world.
The president sketched out his priorities for the first 25
million doses from that pledge earlier this month.

The United States has come under pressure to share more of
its vaccine supply with countries that are still struggling with
the deadly virus and its variants. With more and more Americans
getting the shots, the White House increasingly has turned its
attention to getting vaccine out internationally. (Graphic on
global vaccinations) https://tmsnrt.rs/3tUM8ta

Of the 55 million remaining doses, some 41 million will be
shared through COVAX, the White House said, with approximately
14 million going to Latin America and the Caribbean, some 16
million to Asia, and roughly 10 million to Africa.

The other 25%, or roughly 14 million doses, will be shared
with "regional priorities," including Colombia, Argentina, Iraq,
Ukraine, the West Bank and Gaza.

White House spokeswoman Jen Psaki said the United States had
faced logistical issues getting vaccine to other nations.

"We have plenty of doses to share with the world, but this
is a Herculean logistical challenge," she told reporters, noting
safety and regulatory information had to be shared, proper
storage temperatures for the vaccines had to be ensured, and
language barriers at times had to be overcome.

"We have announced today where these doses are going. We
will continue to announce as they land on the ground and as they
are being shipped, and we're looking forward to doing that as
quickly as possible," she said.

The 55 million doses will be taken from the U.S. supply of
Pfizer Inc, Moderna Inc, and Johnson & Johnson
shots, though if AstraZeneca's vaccine gets a
green light from the Food and Drug Administration, it would
likely be added to the mix as well.

The White House said it wanted the doses to be prioritized
for health care workers and those who are most at risk.

International partners are eager to get U.S. help. Biden has
announced the United States will buy 500 million doses of
Pfizer's vaccine and donate them to the world's poorest
countries.

The White House's breakdown of its allocation of the 55
million vaccine doses is below.

THROUGH COVAX:

* Latin America and the Caribbean (approximately 14 million
shots): Brazil, Argentina, Colombia, Peru, Ecuador, Paraguay,
Bolivia, Uruguay, Guatemala, El Salvador, Honduras, Haiti, and
other Caribbean Community (CARICOM) countries, Dominican
Republic, Panama, and Costa Rica

* Asia (approximately 16 million shots): India, Nepal,
Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan,
Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua
New Guinea, Taiwan, Cambodia, and the Pacific Islands.

* Africa (approximately 10 million shots): Recipient
countries will be selected in coordination with the African
Union.

THROUGH DIRECT SHARING: Colombia, Argentina, Haiti, other
CARICOM countries, Dominican Republic, Costa Rica, Panama,
Afghanistan, Bangladesh, Pakistan, Philippines, Vietnam,
Indonesia, South Africa, Nigeria, Kenya, Ghana, Cabo Verde,
Egypt, Jordan, Iraq, Yemen, Tunisia, Oman, West Bank and Gaza,
Ukraine, Kosovo, Georgia, Moldova, and Bosnia.

(Reporting by Jeff Mason
Additional reporting by Trevor Hunnicutt and Nandita Bose
Editing by Chizu Nomiyama and Lisa Shumaker)

More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.